Abstract: Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
Type:
Grant
Filed:
March 26, 2018
Date of Patent:
February 1, 2022
Assignee:
DXM Pharmaceutical, Inc.
Inventors:
Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
Abstract: Liquid formulations or syrup comprise an over-the-counter API ingredient or a dietary supplement ingredient. The ingredients are present in concentrated amounts. Multiple doses of the syrups may be packaged in relatively small bottles, such as bottles with a capacity of 100 ml or less.
Type:
Application
Filed:
June 9, 2020
Publication date:
March 11, 2021
Applicant:
DXM Pharmaceuticals, Inc.
Inventors:
Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
Abstract: Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
Type:
Application
Filed:
March 26, 2018
Publication date:
September 27, 2018
Applicant:
DXM Pharmaceutical, Inc.
Inventors:
Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister